Literature DB >> 23517932

Concept for a rapid point-of-care calprotectin diagnostic test for diagnosis and disease activity monitoring in patients with inflammatory bowel disease: expert clinical opinion.

Gerhard Rogler1, Xavier Aldeguer, Wolfgang Kruis, Anders Lasson, Ulrich Mittmann, Ken Nally, Laurent Peyrin-Biroulet, Alain Schoepfer, Morten Vatn, Stephan Vavricka, Robert Logan.   

Abstract

Entities:  

Keywords:  Crohn's disease; Diagnostic tests; Inflammatory bowel disease; Irritable bowel syndrome; Ulcerative colitis

Mesh：

Substances：

Year:  2013        PMID： 23517932     DOI： 10.1016/j.crohns.2013.02.014

Source DB:  PubMed          Journal:  J Crohns Colitis        ISSN： 1873-9946            Impact factor:   9.071


× No keyword cloud information.
  12 in total

1.  Response to Levenstein and Prantera.

Authors:  David J Gracie; Christopher J M Williams; Ruchit Sood; Saqib Mumtaz; M Hassan Bholah; P John Hamlin; Alexander C Ford
Journal:  Am J Gastroenterol       Date:  2016-10       Impact factor: 10.864

2.  Rapid Fecal Calprotectin Test and Symptom Index in Monitoring the Disease Activity in Colonic Inflammatory Bowel Disease.

Authors:  Anna-Maija Puolanne; Kaija-Leena Kolho; Henrik Alfthan; Ari Ristimäki; Harri Mustonen; Martti Färkkilä
Journal:  Dig Dis Sci       Date:  2017-09-25       Impact factor: 3.199

Review 3.  Clinical Utility of Biomarkers in IBD.

Authors:  Gerhard Rogler; Luc Biedermann
Journal:  Curr Gastroenterol Rep       Date:  2015-07

4.  Poor Correlation Between Clinical Disease Activity and Mucosal Inflammation, and the Role of Psychological Comorbidity, in Inflammatory Bowel Disease.

Authors:  David J Gracie; Christopher J M Williams; Ruchit Sood; Saqib Mumtaz; M Hassan Bholah; P John Hamlin; Alexander C Ford
Journal:  Am J Gastroenterol       Date:  2016-03-22       Impact factor: 10.864

Review 5.  From bench to bedside: Fecal calprotectin in inflammatory bowel diseases clinical setting.

Authors:  Maria Gloria Mumolo; Lorenzo Bertani; Linda Ceccarelli; Gabriella Laino; Giorgia Di Fluri; Eleonora Albano; Gherardo Tapete; Francesco Costa
Journal:  World J Gastroenterol       Date:  2018-09-07       Impact factor: 5.742

6.  Randomized controlled trial: a pilot study of a psychoeducational intervention for fatigue in patients with quiescent inflammatory bowel disease.

Authors:  Anthony O'Connor; Raguprakash Ratnakumaran; Lisa Warren; Debbie Pullen; Anna Errington; David J Gracie; Rebecca C Sagar; P John Hamlin; Alexander C Ford
Journal:  Ther Adv Chronic Dis       Date:  2019-03-26       Impact factor: 5.091

7.  Impact of faecal calprotectin measurement on clinical decision-making in patients with Crohn's disease and ulcerative colitis.

Authors:  Anna Luisa Bathe; Eirini Mavropoulou; Nicolae-Catalin Mechie; Golo Petzold; Volker Ellenrieder; Steffen Kunsch; Ahmad Amanzada
Journal:  PLoS One       Date:  2019-10-24       Impact factor: 3.240

8.  Rapid fecal calprotectin testing to assess for endoscopic disease activity in inflammatory bowel disease: A diagnostic cohort study.

Authors:  Lukasz Kwapisz; Mahmoud Mosli; Nilesh Chande; Brian Yan; Melanie Beaton; Jessica Micsko; Pauline W Mennill; William Barnett; Kevin Bax; Terry Ponich; John Howard; Anthony Tirolese; Robert Lannigan; James Gregor
Journal:  Saudi J Gastroenterol       Date:  2015 Nov-Dec       Impact factor: 2.485

9.  Detection of calprotectin in inflammatory bowel disease: Fecal and serum levels and immunohistochemical localization.

Authors:  Shuhei Fukunaga; Kotaro Kuwaki; Keiichi Mitsuyama; Hidetoshi Takedatsu; Shinichiro Yoshioka; Hiroshi Yamasaki; Ryosuke Yamauchi; Atsushi Mori; Tatsuyuki Kakuma; Osamu Tsuruta; Takuji Torimura
Journal:  Int J Mol Med       Date:  2017-11-07       Impact factor: 4.101

10.  Factors affecting clinical decision-making in inflammatory bowel disease and the role of point-of-care calprotectin.

Authors:  Yannick Derwa; Christopher J M Williams; Ruchit Sood; Saqib Mumtaz; M Hassan Bholah; Christian P Selinger; P John Hamlin; Alexander C Ford; David J Gracie
Journal:  Therap Adv Gastroenterol       Date:  2018-01-18       Impact factor: 4.409
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.